Eisai Introduces Rx-to-OTC Switch Product For Allergy-related Rhinitis And Skin Problems

Eisai has introduced a Rx-to-OTC switch product for allergic-related rhinitis and skin problems, available from November 1.

The product, 'Higuard', is the first Rx-to-OTC switch product of azelastine hydrochloride, an anti-allergy compound originally approved for prescription use. It is also effective in alleviating allergyc symptoms including rhinitis caused by pollens or house dusts and skin problems such as utricaria and eczema.

The active ingredient of Higuard azelastine hydrochloride exhibits anti-allergic effects by inhibiting and releasing leukotriens and histamine that cause allergy, relieving allergic symptoms including rhinitis (sneezing, runny and stuffy nose) and skin problems (urticaria, eczema, etc).

It is recommended that patients with seasonal allergic diseases be started on Higuard immediately before the beginning of the season to maximize the effect.

According to an Eisai survey, more than 50 percent of the people who suffer from pollen allergy answered that they constantly feel itching of skin, and 70 percent said that they experience allergic problems all year. Higuard is expected to serve the needs of such people acting on both rhinitis and skin problems.

By Chris Lui, JCN Staff Writer

Copyright © 2006 JCN. All rights reserved. A division of Japan Corporate News Network KK.

JCN